首页|期刊导航|中华医学杂志（英文版）|Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

Mucong Li Mengtao Li Lin Qiao Chanyuan Wu Dong Xu Yan Zhao Xiaofeng Zeng

中华医学杂志（英文版）2023，Vol.136Issue(19)：2297-2306,10.

中华医学杂志（英文版）2023，Vol.136Issue(19)：2297-2306,10.DOI:10.1097/CM9.0000000000002539

Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

Mucong Li ¹Mengtao Li ¹Lin Qiao ¹Chanyuan Wu ¹Dong Xu ¹Yan Zhao ¹Xiaofeng Zeng¹

作者信息

1. Department of Rheumatology and Clinical Immunology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College||National Clinical Research Center for Dermatologic and Immunologic Diseases(NCRC-DID),Ministry of Science & Technology||State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital(PUMCH)||Key Laboratory of Rheumatology and Clinical Immunology,Ministry of Education,Beijing 100730,China
折叠

摘要

关键词

Primary Sjögren's syndrome/JAK-STAT pathway/Janus kinase inhibitors/Disease-modifying antirheumatic drugs

Key words

Primary Sjögren's syndrome/JAK-STAT pathway/Janus kinase inhibitors/Disease-modifying antirheumatic drugs

引用本文复制引用

Mucong Li,Mengtao Li,Lin Qiao,Chanyuan Wu,Dong Xu,Yan Zhao,Xiaofeng Zeng..Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome[J].中华医学杂志（英文版）,2023,136(19):2297-2306,10.

基金项目

This study was supported by grants from the Chinese National Key Technology R&D Program,Ministry of Science and Technology(Nos.2017YFC0907601,2017YFC0907605),and CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2021-I2M-1-005). （Nos.2017YFC0907601,2017YFC0907605）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航